Literature DB >> 22157862

Dopamine D3 receptor function and cocaine exposure.

Brandi L Blaylock1, Michael A Nader.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22157862      PMCID： PMC3238064          DOI： 10.1038/npp.2011.170

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  5 in total

1.  Influence of cocaine history on the behavioral effects of Dopamine D(3) receptor-selective compounds in monkeys.

Authors:  B L Blaylock; R W Gould; A Banala; P Grundt; R R Luedtke; A H Newman; M A Nader
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

2.  Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity.

Authors:  Gregory T Collins; Yen Nhu-Thi Truong; Beth Levant; Jianyong Chen; Shaomeng Wang; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2011-01-05       Impact factor: 4.530

Review 3.  Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.

Authors:  Christian A Heidbreder; Amy H Newman
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

4.  Characterization of the dopamine receptor system in adult rhesus monkeys exposed to cocaine throughout gestation.

Authors:  Lindsey R Hamilton; Paul W Czoty; H Donald Gage; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2010-04-20       Impact factor: 4.530

5.  Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists.

Authors:  Gregory T Collins; Amy Hauck Newman; Peter Grundt; Kenner C Rice; Stephen M Husbands; Cédric Chauvignac; Jianyong Chen; Shaomeng Wang; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2007-03-29       Impact factor: 4.530
  5 in total
  4 in total

1.  Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55.

Authors:  Timothy H C Cheung; Amy L Loriaux; Suzanne M Weber; Kayla N Chandler; Jeffrey D Lenz; Romina F Schaan; Robert H Mach; Robert R Luedtke; Janet L Neisewander
Journal:  J Pharmacol Exp Ther       Date:  2013-09-09       Impact factor: 4.030

2.  Dopamine D₃ receptor alterations in cocaine-dependent humans imaged with [¹¹C](+)PHNO.

Authors:  David Matuskey; Jean-Dominique Gallezot; Brian Pittman; Wendol Williams; Jane Wanyiri; Edward Gaiser; Dianne E Lee; Jonas Hannestad; Keunpoong Lim; Minq-Qiang Zheng; Shu-fei Lin; David Labaree; Marc N Potenza; Richard E Carson; Robert T Malison; Yu-Shin Ding
Journal:  Drug Alcohol Depend       Date:  2014-03-20       Impact factor: 4.492

3.  Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats.

Authors:  T H C Cheung; B C Nolan; L R Hammerslag; S M Weber; J P Durbin; N A Peartree; R H Mach; R R Luedtke; J L Neisewander
Journal:  Neuropharmacology       Date:  2012-08-31       Impact factor: 5.250

Review 4.  Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease.

Authors:  Monique E Maubert; Vanessa Pirrone; Nina T Rivera; Brian Wigdahl; Michael R Nonnemacher
Journal:  Front Microbiol       Date:  2016-01-11       Impact factor: 5.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.